Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients.
Natural History of Multiple Sclerosis Symptoms
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom.
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Progress in multiple sclerosis research in the last year.
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
Study Suggests Targeting B Cells May Help with MS
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Moving towards the pan-European unification of Multiple Sclerosis Nurses: a consensus paper.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
Systematic approaches to central nervous system myelin.
Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Early Growth Response Gene-2 Controls IL-17 Expression and Th17 Differentiation by Negatively Regulating Batf.
Tysabri
Pages
« first
‹ previous
…
108
109
110
111
112
113
114
115
116
…
next ›
last »